Abstract
Transferrin is a glycosylated metal-binding serum protein. Carbohydrate-deficient transferrin (CDT) is a marker of recent and heavy alcohol intake. A genetic variant of transferrin, TfC2, occurs with increased frequency in patients with Alzheimer's disease (AD). Hence the question arose whether, in addition to an altered amino acid sequence, there could also be a difference in the glycosylation state of transferrin in patients with dementia. Serum samples of 37 AD and 13 Alcohol-induced dementia patients as well as 10 healthy controls were analyzed for abnormal Tf variants, using isoelectric focusing followed by blotting with anti-Tf antibodies. This allowed the direct visualization of glycosylation variants of transferrin, and assessment of any increase in underglycosylated forms (di-, mono-and asialo transferrin).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Albertyn, C., and McCann, M. (1993). Alcohol, Employment and Fair Labour Practice. Juta & Co., Cape Town, South Africa.
Allen, J., and Sillanaukee, P. (1999). Carbohydrate-deficient transferrin is a useful marker for the detection of chronic alcohol abuse. Eur. J. Clin. Invest. 29:899-900.
Beckman, L., and Beckman G. (1986). Transferrin C2 as an enhancer of cyto-and genotoxic damage. Prog. Clin. Biol. Res. 209B:221-224.
De Jong, G., Van Noort, W.L., and Van Eijk, H.G. (1992). Carbohydrate analysis of transferrin subfractions isolated by preparative isoelectric focusing in immobilized pH gradients. Electrophoresis 13:225-228.
Jeppsson, J.O., Kristensson, H., and Fimiani, C. (1993). Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin. Chem. 39:2115-2120.
Namekata, K., Imagawa, M., Terashi, A., Ohta, S., Oyama, F., and Ihara, Y. (1997). Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum. Genet. 101:126-129.
Petrén. S., and Vesterberg, O. (1989). Separation of different forms of transferrin by isoelectric focusing to detect effects on the liver caused by xenobiotics. Electrophoresis 10:600-604.
Potocnik. F.C.V., van Rensburg, S.J., Taljaard, J.J.F., and Emsley, R.A. (1997). Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vivo effect of zinc on platelet membranes and cognition. S. Afr. Med. J. 87:1116-1119.
Schmitt, U.M., Stieber, P., Jüngst, D., Bilzer, M., Wächtler, M., Heberger, S., and Seidel D. (1998). Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur. J. Clin. Invest. 28:615-621.
Stibler, H., Borg, S., and Joustra, M. (1986). Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish patent 8400587-5). Alcoholism: Clinical and Experimental Research 10:535-544.
Stibler, H. (1991). Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin. Chem. 37:2029-2037.
Van Landeghem, G.F., Sikström, C., Beckman, L.E., Adolfsson, R., and Beckman, L. (1998). Transferrin C2, metal binding and Alzheimer's disease. NeuroReport 9:177-179.
van Rensburg, S.J., Carstens, M.E., Potocnik, F.C.V., Aucamp, A.K., and Taljaard, J.J.F. (1993). Increased frequency of the transferrin C2 subtype in Alzheimer's disease. NeuroReport 4:1269-1271.
Xin, Y., Rosman, A.S., Lasker, J.M. and Lieber, C.S. (1992). Measurement of carbohydrate-deficient transferrin by isoelectric focusing/Western blotting and by micro anion-exchange chromatography/radioimmunoassay: comparison of diagnostic accuracy. Alcohol 27:425-433.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Rensburg, S., Berman, P., Potocnik, F. et al. Glycosylation of Transferrin in Alzheimer's Disease and Alcohol-Induced Dementia. Metab Brain Dis 15, 243–247 (2000). https://doi.org/10.1023/A:1011162922786
Issue Date:
DOI: https://doi.org/10.1023/A:1011162922786